Skip to content
Aussie8 – Lifestyle
Author:
BERRY & COMPANY PUBLIC RELATIONS
Solu Therapeutics Granted FDA Fast Track Designation for STX-0712 for Treatment of Chronic Myelomonocytic Leukemia
May 27, 2026
GRIN Therapeutics’ Pivotal Phase 3 Beeline Study Initiated in Europe
May 4, 2026
ITF Therapeutics LLC Presents New Data and Analyses on Givinostat for Treatment of Duchenne Muscular Dystrophy at 2026 MDA Clinical and Scientific Conference
March 9, 2026